All Updates

All Updates

icon
Filter
Partnerships
BioAI partners with Genomic Testing Cooperative to develop AI-enabled digital pathology services for oncology
Precision Medicine
Jun 25, 2024
This week:
Partnerships
Qualcomm and Google partner to develop AI-driven automotive solutions
Auto Tech
Yesterday
Product updates
Meta AI releases LayerSkip to accelerate inference in LLMs
Generative AI Infrastructure
Yesterday
Funding
Freeform secures funding from NVIDIA's NVentures
Additive Manufacturing
Oct 22, 2024
Product updates
Flexxbotics announces compatibility with LMI Technologies for quality inspection
Smart Factory
Oct 22, 2024
Funding
Oxla raises USD 11 million in seed funding to drive commercialization
Data Infrastructure & Analytics
Oct 22, 2024
Product updates
Cohesity enhances Gaia, its AI assistant, with visual data exploration and expanded data sources
Data Infrastructure & Analytics
Oct 22, 2024
Product updates
Finzly launches FedNow service through BankOS platform in AWS marketplace
FinTech Infrastructure
Oct 22, 2024
Product updates
Runway launches Act-One for AI facial expression motion capture
Generative AI Applications
Oct 22, 2024
Product updates
Ideogram launches Canvas for image manipulation and generation
Generative AI Applications
Oct 22, 2024
Partnerships
UiPath partners with Inflection AI to integrate AI solutions for enterprises
Generative AI Applications
Oct 22, 2024
Precision Medicine

Precision Medicine

Jun 25, 2024

BioAI partners with Genomic Testing Cooperative to develop AI-enabled digital pathology services for oncology

Partnerships

  • BioAI Health and Genomic Testing Cooperative (GTC) have partnered to leverage their AI capabilities to create advanced solutions for oncology diagnostics and clinical research. Under the partnership, GTC will become an early technology access member of BioAI's global clinical laboratories.

  • The collaboration involves GTC providing BioAI access to its characterized imaging data, enabling BioAI to refine and develop its AI algorithms. It also focuses on the joint development of genomic biomarker screening algorithms and assays for use in clinical settings and introduces a range of diagnostic solutions, including screening tests and comprehensive genomic profiling using DNA and RNA for tissue and liquid biopsies.

  • BioAI Health is a biotechnology company that leverages advanced AI for precision medicine. It focuses on mapping the causal biology of diseases, developing digital biomarkers, and identifying novel drug targets. Its key offerings include AI-driven biomarker services, drug discovery, and data sourcing. BioAI uses technological platforms such as PredictX and In-Silico Phenotype Projection to enhance genetic mutation identification and drug target discovery, helping to accelerate the clinical R&D process.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.